KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer
about
Krüppel-like factors: three fingers in controlNEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancerKrüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasisMetastasis suppressor genesTranscriptional control of cancer metastasisRegulation of mesenchymal phenotype by MicroRNAs in cancerGain of function of mutant p53: R282W on the peak?Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasisMetastasis suppressor genes at the interface between the environment and tumor cell growthLong noncoding RNAs with enhancer-like function in human cellsLIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinaseThe role of nuclear factor I-C in tooth and bone development.Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system.EMT is the dominant program in human colon cancer.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expressionKrüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionmaCyclin D1, Id1 and EMT in breast cancer.Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming.A primer on using pooled shRNA libraries for functional genomic screensID1 promotes breast cancer metastasis by S100A9 regulation.Genomics screens for metastasis genesNuclear factor I-C (NFIC) regulates dentin sialophosphoprotein (DSPP) and E-cadherin via control of Krüppel-like factor 4 (KLF4) during dentinogenesis.A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.Antitumor action of a novel histone deacetylase inhibitor, YF479, in breast cancer.Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.Metastasis suppressors and the tumor microenvironmentExpression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer.Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progressionKrüppel-like factors are effectors of nuclear receptor signaling.Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.Diverse factors are involved in maintaining X chromosome inactivationID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis.Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data.The evolution of tumor metastasis during clonal expansion with alterations in metastasis driver genesLow expression of KLF17 is associated with tumor invasion in esophageal carcinoma.Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
P2860
Q21093250-A42FA2B9-AED8-4A68-BABC-68FC6D31833EQ21560948-292AABF4-1760-4607-919A-F0121CB4F4B8Q26776349-26772B75-8E4A-4594-ADFE-368810B2F0F5Q26866948-5E871CFF-AB69-4531-8963-DC42247DF4CBQ26992024-106FA81C-43A2-4421-82DC-B875BF982F96Q27009506-B68E307C-277E-47C5-9328-16181ECCCAC8Q28068551-37E28025-0E55-4CC2-990D-6AB1900BB288Q28241878-29D8F108-9026-461F-B0E8-64079F5E5802Q28394526-72A831E1-8B16-4C19-BBFA-7BC774ACDF54Q29614328-AF3B5363-41F9-42B1-BD5C-6262E8E10335Q30588724-AB30B4ED-DBCF-456D-9ABC-D555EBDD616BQ33619118-8CCF515A-F23C-475D-B288-48BDCF0C5FBEQ33668830-73C70ECC-4F9C-468A-9F2B-7CEAE630F9D1Q33798739-9F2CD88A-A281-438C-9409-E46BF9096C1DQ33872622-26832803-B898-4352-8BE6-5750C343B23EQ33883339-22603201-3549-4627-88D2-6767D4289157Q33888940-9604105C-CF60-469C-AF4F-71DA4549018AQ34034112-F2E40ADA-3656-4C06-910A-654788DC6CF9Q34048090-E7D6CBB4-0F3B-45CB-8950-F3E66D264619Q34076037-5BCBF666-542B-48E9-86B9-4AF966D80DC9Q34137070-9E87744A-011B-463E-82CA-EE629F8A4135Q34177858-9AE5637A-9745-4E5A-9FA0-4702AB30B24AQ34298860-ECD615D0-8AE7-4F81-8C54-F78BD21E0B65Q34317321-89415281-FA70-4F2F-9AB7-78C0DA852699Q34362408-C23BAD12-3753-4E44-8536-0D35D39254D4Q34528291-47E90F14-AA34-4A9E-ACB5-FB048E17705DQ34531593-AD290588-5882-4C5C-985B-F54BCECF4E22Q34648929-81522B97-51F7-4C1E-A956-AD90037843C8Q34971817-AED1046B-6101-47CD-97E4-790A0AB2C4BFQ34999819-CC1F6520-49EB-4D7D-ABCB-1A5A9434A6B9Q35116300-7AF98164-F5F4-42AF-BD14-4EBC6FAA4C88Q35224616-55CEF4EA-2E2A-48B7-B77D-333BB6A1379CQ35274546-65252981-DF3B-48F9-B948-4AD7664C62CBQ35289356-B3948685-3AF0-4942-A346-0843F8AD1700Q35618867-B0CF8C64-0803-40CE-86EE-67824068085EQ35888486-E7C10EEB-2DC2-4D55-B38C-6FC97A2FC986Q36062094-FE4742EF-E0CA-442F-88F9-3864AFC22BCAQ36227108-4B37BA24-53E7-4820-9C91-5C74D5D40FB1Q36261674-787E6B2B-B91A-4C0D-A69B-648E36B86842Q36307011-B7A107C0-D280-46D9-AA08-BB6F703B3A96
P2860
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer
description
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/11/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/11/01)
@nl
наукова стаття, опублікована в листопаді 2009
@uk
مقالة علمية (نشرت في نوفمبر 2009)
@ar
name
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@ast
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@en
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@nl
type
label
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@ast
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@en
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@nl
prefLabel
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@ast
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@en
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
KLF17 is a negative regulator ...... nd metastasis in breast cancer
@en
P2093
Andres J. Klein-Szanto
Dionyssios Katsaros
George Coukos
Kiranmai Gumireddy
Louise C. Showe
Phyllis A. Gimotty
Qihong Huang
P2860
P2888
P304
P3181
P356
10.1038/NCB1974
P577
2009-11-01T00:00:00Z
P5875
P6179
1011609648